These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 23524663
21. Distribution of [2-14C]merbarone in mice by autoradiography of whole-body cryosections. Kemmenoe BH, Malspeis L. Cancer Res; 1987 Feb 15; 47(4):1135-42. PubMed ID: 3802094 [Abstract] [Full Text] [Related]
22. Pharmacokinetics of human activated protein C. 2nd communication: tissue distribution study of a lyophilized purified human activated protein C after single or repeated intravenous administration in male mice and placental transfer and milk passage study after intravenous administration in pregnant and lactating mice. Ishii S, Mochizuki T, Nagao T, Kudo S, Fujita A, Taniguchi K, Kondo S, Kiyoki M. Arzneimittelforschung; 1995 May 15; 45(5):644-56. PubMed ID: 7612069 [Abstract] [Full Text] [Related]
23. Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14 C-bortezomib. Hemeryck A, Geerts R, Monbaliu J, Hassler S, Verhaeghe T, Diels L, Verluyten W, van Beijsterveldt L, Mamidi RN, Janssen C, De Coster R. Cancer Chemother Pharmacol; 2007 Nov 15; 60(6):777-87. PubMed ID: 17285316 [Abstract] [Full Text] [Related]
29. Disposition and metabolism of radiolabeled casopitant in humans. Pellegatti M, Bordini E, Fizzotti P, Roberts A, Johnson BM. Drug Metab Dispos; 2009 Aug 15; 37(8):1635-45. PubMed ID: 19420128 [Abstract] [Full Text] [Related]
30. Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase C. Zhang X, Zhang R, Zhao H, Cai H, Gush KA, Kerr RG, Pettit GR, Kraft AS. Cancer Res; 1996 Feb 15; 56(4):802-8. PubMed ID: 8631017 [Abstract] [Full Text] [Related]
31. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T, Hayashi T, Okita A, Morino A. Arzneimittelforschung; 1996 Feb 15; 46(2):106-13. PubMed ID: 8720298 [Abstract] [Full Text] [Related]
32. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Kobayashi S, Sakai T, Dalrymple PD, Wood SG, Chasseaud LF. Arzneimittelforschung; 1993 Dec 15; 43(12):1367-77. PubMed ID: 8141830 [Abstract] [Full Text] [Related]
33. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat. Mountfield RJ, Kiehr B, John BA. Drug Metab Dispos; 2000 May 15; 28(5):503-13. PubMed ID: 10772628 [Abstract] [Full Text] [Related]
37. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM, Bao J, Smith RL, McClure TD, Mayersohn M, Pillai U, Cunningham ML, Sipes IG. Drug Metab Dispos; 1997 Mar 15; 25(3):371-8. PubMed ID: 9172957 [Abstract] [Full Text] [Related]
40. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. Ahr HJ, Boberg M, Brendel E, Krause HP, Steinke W. Arzneimittelforschung; 1997 Jun 15; 47(6):734-45. PubMed ID: 9239452 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]